How Genomic Life Transformed Their Medical Device Sales Enablement Process

Genomic Life provides access to cutting-edge genomic testing technologies — a complex, innovative offering that bridges the gap between advanced genomic capabilities and what standard healthcare benefits typically cover. Their services include genomic testing, oncology nurse navigators, clinical trial eligibility testing, and financial navigation tools for patients facing specific diagnoses.

Communicating this to diverse healthcare audiences compliantly and consistently is not a simple sales challenge. Here’s how they solved it.

The Specific Challenges

When Genomic Life evaluated their sales enablement approach, four specific problems emerged.

Uncontrolled content creation. Every rep was creating and modifying their own presentations. The telephone game was playing out in real time — clinical messaging drifted, brand standards eroded, and marketing had no visibility into what was actually reaching healthcare professionals.

Supplier and partner inconsistency. Genomic Life needed confidence that not just internal reps but also suppliers and channel partners were presenting their offerings accurately. With file-based distribution, there was no mechanism to ensure anyone in the extended selling ecosystem was working from current, approved materials.

Complex positioning requirements. Their product model required precise clinical positioning. Inaccurate presentation could lead to misperception as an insurance company or misinterpretation as delivering medical advice — both compliance-significant errors with real commercial consequences.

Regulatory compliance demands. Operating in the regulated medical field meant that content governance wasn’t just a brand concern. It was a legal and operational requirement. A platform that allowed free modification of clinical claims wasn’t a platform they could use.

Why Traditional Digital Asset Management Fell Short

After months of evaluating options, traditional digital asset management systems proved to be more infrastructure than their specific needs required. What Genomic Life actually needed wasn’t just organized storage — it was controlled, governed delivery with the flexibility to customize for different healthcare markets.

The capability that made the difference: mixed content control. The balance between marketing control and sales flexibility is the tension every MedTech company navigates. A system that locks everything defeats the purpose of field customization. A system that allows everything defeats the purpose of brand governance. Genomic Life needed a system that locked clinical claims and regulatory language while allowing reps to customize other sections for specific clinical contexts.

The Capabilities They Gained

After implementation, three specific capabilities changed how the sales organization operated:

Automatic content updates. One of Genomic Life’s core requirements was ensuring reps couldn’t create a presentation, file it locally, and use an outdated version months later. With centrally hosted content delivered as links, every presentation automatically reflects the current version. Combined with engagement analytics that show when and how content is accessed, the team gained full visibility into the content lifecycle from creation to field delivery.

Integrated calculations. Previously, demonstrating ROI to healthcare administrators required separate calculators or spreadsheets alongside the presentation. With interactive calculators built directly into the presentation environment, reps can model outcomes in real time during meetings — without switching tools or creating a disjointed experience for the healthcare buyer.

Market-specific customization. Reps can now edit presentations and individual slides dynamically for specific clinical scenarios, healthcare specialties, and facility types — within the guardrails that compliance requires. Each meeting gets a presentation calibrated to that specific buyer, not a generic deck that tries to serve everyone.

The Marketing and Sales Alignment Outcome

The result that Genomic Life’s marketing team highlighted most was the elimination of what they called “Frankenstein slides” — presentations assembled from pieces of multiple decks, modified without authorization, inconsistent with current brand and clinical standards. Marketing finally had the control they needed. Sales retained the flexibility they needed. The platform created the infrastructure that allowed both to coexist.

Cartessa Aesthetics solved a similar challenge from a different angle — the underlying dynamic is the same across MedTech companies of different sizes and product types: marketing control and sales flexibility are both essential, and only the right platform architecture makes them compatible rather than competitive.

Ready to apply similar governance and flexibility to your team’s content? Book a demo to see how Nuvue’s mixed content control approach works for medical device sales organizations.